BERG, Health Biologics, Genetics & Artificial Intelligence CEO Niven Narain on the Future of Precision Medicine in Cancer Treatment. Berg is a Boston-based company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology platform. This Platform combines patient biology and artificial-intelligence-based analytics to engage the differences between healthy and disease environments. The patients own biology drives the platforms results and guides Berg in the discovery and development of precision drugs.
Listen to MAXIMUM HEALTH, “Quality Living” Radio
with Dr. Ken Grey AP, DOM Holistic Physician
88.9 fm WQCS – NPR every Friday @7 pm
National Public Radio
Podcast: Play in new window | Download